This inventor holds 1 USPTO granted patent. Top assignee: Elanco Animal Health Gmbh. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Thomas Ilg: Innovator in Quinoline Derivatives
Introduction
Thomas Ilg is a notable inventor based in Monheim am Rhein, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his work on quinoline derivatives. His innovative approach has led to advancements in the treatment of various diseases.
Latest Patents
Thomas Ilg holds a patent for quinoline derivatives, which covers new quinoline compounds of general formula (I). The invention includes methods for preparing these compounds, intermediate compounds useful for their preparation, and pharmaceutical compositions that incorporate these compounds. The primary focus of his patent is on the treatment, control, and prevention of diseases, especially helminth infections, either as a sole agent or in combination with other active ingredients. He has 1 patent to his name.
Career Highlights
Ilg is currently associated with Elanco Animal Health GmbH, where he continues to contribute to the development of innovative pharmaceutical solutions. His work is characterized by a commitment to improving health outcomes through scientific research and development.
Collaborations
Throughout his career, Thomas Ilg has collaborated with talented professionals, including Niels Lindner and Maike Hink. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.
Conclusion
Thomas Ilg's contributions to the field of pharmaceuticals, particularly through his patent on quinoline derivatives, highlight his role as an innovator. His work continues to impact the treatment of diseases, showcasing the importance of research and collaboration in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile